What’s in a name?
Posted 31st August 2010 in Articles, Commercial | 1 comment
As the number of terms used in nomenclature of marketing activities increases, Chris Stevenson questions whether it’s time we standardised.
“That which we call a rose, by any other name would smell as sweet”. We may all agree with Juliet that her lover Romeo would…
Read the full articlepharmaphorum celebrates its first birthday!
Posted 27th August 2010 in Articles, General | 6 comments
As pharmaphorum celebrates its first birthday, Paul Tunnah reflects on a year of running a pharma social media site and looks forward to the future.
Well, I can scarcely believe it myself, but pharmaphorum has reached its first birthday! The last year has certainly flown by, but…
Read the full articleWhat Are IDEAs Made Of: Efficacy
Posted 25th August 2010 in Articles, General | 1 comment
The term efficacy is used increasingly in the pharma industry. Mike Rea questions whether the term is used as a banner for anything that fits the bill.
Here’s the thing about Efficacy. It doesn’t exist. It is an abstract concept, a shorthand, a broad clustering of things that…
Read the full articleLooking beyond pharma for portfolio optimisation
Posted 23rd August 2010 in Articles, Commercial | 1 comment
Trevor Brown outlines an exciting new project where pharma is looking to learn from other industries about how to improve portfolio management and optimisation.
Within an increasingly challenging environment, there is significant debate in the pharmaceutical industry directed at…
Read the full articleEngaging OLs ‘over time’ online for greater insight
Posted 19th August 2010 in Articles, Commercial | 5 comments
In a time-pressured, geographically-vast industry, Neil A. Jones discusses what should be considered to ensure effective online engagement with Opinion Leaders.
Despite all the promises of the web to engage opinion leaders and other key stakeholders online for…
Read the full articleA team management guide (part 2)
Posted 17th August 2010 in Articles, General | Register to comment
In the second and final part of this two part series, Sue Wright highlights the remaining steps managers can take to develop and lead successful teams.
In the first part of this article, I introduced the seven key elements critical to success in leadership and covered off the first four…
Read the full articleWhat Are IDEAs Made Of: Brand names
Posted 13th August 2010 in Articles, Commercial | 1 comment
Mike Rea returns to question whether sufficient consideration is put into drug brand names. Are we playing it too safe?
This is not an industry that does what is easy instead of what is best.
This is not an industry that would ever…
A team management guide (part 1)
Posted 10th August 2010 in Articles, General | 2 comments
In the first part of this two part series, Sue Wright provides practical guidance to managers and details the critical steps to effective team leadership.
In addition to the specialist knowledge necessary for a functional team to operate successfully, there are also techniques and skills…
Read the full articleUnderstanding “strategy”
Posted 5th August 2010 in Articles, Commercial | 4 comments
Welcoming back a previous author now in a new role, pharmaphorum finds Pete West perplexed to find so many people talking at cross-purposes about strategy.
Have you ever been half way through a conversation with someone and suddenly realised that the thing you thought you were discussing…
Read the full articleHow about considering profitable segmentation?
Posted 3rd August 2010 in Articles, Commercial | 2 comments
As competition continues to increase within the pharmaceutical world, Dr. Andree Bates advises on the benefits of customer segmentation and targeted marketing.
In today’s dynamic and competitive pharmaceutical environment, being able to effectively target your…
Read the full article